Stock Analysis on Net
Stock Analysis on Net

Cytokinetics Inc. (NASDAQ:CYTK)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Debt to Equity 
since 2005

Microsoft Excel

Calculation

Cytokinetics Inc., debt to equity, long-term trends, calculation

Microsoft Excel
Debt to equity = Debt1 ÷ Stockholders’ equity (deficit)1
Dec 31, 2022 — = 609,618 ÷ (107,900)
Dec 31, 2021 0.59 = 142,838 ÷ 243,863
Dec 31, 2020 1.20 = 135,713 ÷ 113,383
Dec 31, 2019 — = 129,257 ÷ (10,937)
Dec 31, 2018 1.64 = 42,413 ÷ 25,934
Dec 31, 2017 0.29 = 31,777 ÷ 109,842
Dec 31, 2016 0.32 = 29,881 ÷ 94,361
Dec 31, 2015 0.21 = 14,639 ÷ 68,590
Dec 31, 2014 0.00 = — ÷ 92,064
Dec 31, 2013 0.00 = — ÷ 54,442
Dec 31, 2012 0.00 = — ÷ 70,085
Dec 31, 2011 0.00 = 152 ÷ 48,178
Dec 31, 2010 0.01 = 985 ÷ 70,516
Dec 31, 2009 0.03 = 2,601 ÷ 101,428
Dec 31, 2008 0.09 = 4,640 ÷ 49,766
Dec 31, 2007 0.09 = 8,689 ÷ 99,916
Dec 31, 2006 0.10 = 10,835 ÷ 106,313
Dec 31, 2005 0.13 = 9,362 ÷ 73,561

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands

Comparison to Competitors

Cytokinetics Inc., debt to equity, long-term trends, comparison to competitors

Microsoft Excel
Cytokinetics Inc. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Vertex Pharmaceuticals Inc.
Dec 31, 2022 — 3.67 10.64 1.27 0.39 1.52 1.19 0.52 0.67 0.37 0.12 0.78 0.03
Dec 31, 2021 0.59 4.98 4.97 1.24 0.49 1.88 1.27 0.46 0.87 0.50 0.14 0.85 0.06
Dec 31, 2020 1.20 6.58 3.51 1.34 0.53 2.94 1.73 0.56 1.26 0.63 0.24 0.63 0.07
Dec 31, 2019 — — 3.09 0.91 0.72 5.88 1.09 0.47 1.02 0.83 0.06 0.60 0.09
Dec 31, 2018 1.64 — 2.71 0.52 0.35 1.30 1.28 0.51 0.94 0.66 0.08 0.69 0.13
Dec 31, 2017 0.29 7.33 1.40 0.68 0.40 1.18 1.64 0.57 0.71 0.60 0.11 0.83 0.29
Dec 31, 2016 0.32 7.95 1.16 0.41 0.53 0.74 1.39 0.39 0.62 0.71 0.11 0.77 0.71
Dec 31, 2015 0.21 8.03 1.12 0.47 0.54 0.55 1.20 0.28 0.59 0.60 0.10 0.59 0.86
Dec 31, 2014 0.00 8.62 1.19 0.53 0.15 0.52 0.80 0.27 0.44 0.51 0.18 0.71 0.75
Dec 31, 2013 0.00 3.28 1.45 0.55 0.16 0.30 0.58 0.25 0.50 0.48 0.26 0.62 0.36
Dec 31, 2012 0.00 4.66 1.39 0.54 0.28 0.37 0.88 0.25 0.39 0.46 0.37 0.46 0.68
Dec 31, 2011 0.00 — 1.13 0.34 0.31 0.52 1.13 0.34 0.32 0.47 0.90 0.47 0.58
Dec 31, 2010 0.01 — 0.56 0.35 0.21 0.56 0.59 0.30 0.33 0.50 0.31 0.14 1.07
Dec 31, 2009 0.03 — 0.47 0.43 0.25 0.70 0.18 0.29 0.30 0.54 0.27 0.14 0.14
Dec 31, 2008 0.09 — 0.50 0.55 0.27 1.55 0.31 0.28 0.33 0.30 0.00 0.14 1.20
Dec 31, 2007 0.09 — 0.63 0.59 0.41 0.37 0.38 0.22 0.32 0.20 0.43 0.15 0.07
Dec 31, 2006 0.10 — 0.48 0.74 0.37 0.34 0.77 0.17 0.39 0.11 0.92 0.19 0.24
Dec 31, 2005 0.13 — 0.19 0.77 0.21 0.60 0.10 0.07 0.45 0.27 1.75 0.21 0.75

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Cytokinetics Inc., debt to equity, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Cytokinetics Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2022 — 0.80
Dec 31, 2021 0.59 0.93
Dec 31, 2020 1.20 1.12
Dec 31, 2019 — 1.09
Dec 31, 2018 1.64 0.93
Dec 31, 2017 0.29 0.87
Dec 31, 2016 0.32 0.79
Dec 31, 2015 0.21 0.68
Dec 31, 2014 0.00 0.55
Dec 31, 2013 0.00 0.52
Dec 31, 2012 0.00 0.51
Dec 31, 2011 0.00 0.46
Dec 31, 2010 0.01 0.40
Dec 31, 2009 0.03 0.39
Dec 31, 2008 0.09 0.37
Dec 31, 2007 0.09 0.30
Dec 31, 2006 0.10 0.25
Dec 31, 2005 0.13 0.29

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Cytokinetics Inc., debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel
Cytokinetics Inc. Health Care
Dec 31, 2022 — 0.72
Dec 31, 2021 0.59 0.79
Dec 31, 2020 1.20 0.90
Dec 31, 2019 — 0.91
Dec 31, 2018 1.64 0.87
Dec 31, 2017 0.29 0.80
Dec 31, 2016 0.32 0.75
Dec 31, 2015 0.21 0.68
Dec 31, 2014 0.00 0.52
Dec 31, 2013 0.00 0.49
Dec 31, 2012 0.00 0.51
Dec 31, 2011 0.00 0.46
Dec 31, 2010 0.01 0.42
Dec 31, 2009 0.03 0.41
Dec 31, 2008 0.09 0.41
Dec 31, 2007 0.09 0.36
Dec 31, 2006 0.10 0.33
Dec 31, 2005 0.13 0.30

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).